Page last updated: 2024-10-28

guanethidine and Diabetic Glomerulosclerosis

guanethidine has been researched along with Diabetic Glomerulosclerosis in 2 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TEUSCHER, A1
LUGINBUEHL, H1
Vertes, V1
Cangiano, JL1
Berman, LB1
Gould, A1

Other Studies

2 other studies available for guanethidine and Diabetic Glomerulosclerosis

ArticleYear
[ANTIHYPERTENSIVE PROPERTIES OF A MONOAMINE OXIDASE INHIBITOR (DL-SERINE-N2-ISOPROPYLHYDRAZIDE: RO 4-1038). CLINICAL RESULTS AND EFFECT ON RENAL FUNCTION].
    Cardiologia, 1964, Volume: 45

    Topics: Antihypertensive Agents; Blood Pressure Determination; Chemical and Drug Induced Liver Injury; Chlor

1964
Hypertension in end-stage renal disease.
    The New England journal of medicine, 1969, May-01, Volume: 280, Issue:18

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Black People; Blood Pressure; Body Weight; Chronic

1969